PRL and mixed anxiety and depressive disorder: At the same time, ZZCD could affect and participate in the process of neuroactive ligand/receptor interaction, regulate the HPA axis and secretion of prolactin and estrogen, and interfere with MAPK and TNF signaling pathways to reduce the level of inflammation to treat anxiety depression.